We have recently demonstrated that platelet rGSK‐3β elevation, olfactory dysfunction and APOE ε4 genetype were positively correlated to the cognitive decline in T2DM patients (Z. P. Xu et al., 2016). This evidence concerns the gene APOE and type 2 diabetes mellitus.